FOS-like antigen 1 is a prognostic biomarker in hepatocellular carcinoma

Background/Aim: The prognosis of hepatocellular carcinoma (HCC) is very dismal and the targeted drugs of HCC are limited. Studies of HCC prognostic biomarkers have made little progress, though many new techniques such as high-throughput sequencing have been applied. FOS-like antigen 1 (FOSL1) is gen...

Full description

Bibliographic Details
Main Authors: Li Li, Wenqi Zhang, Shanshan Zhao, Mao Sun
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2019;volume=25;issue=6;spage=369;epage=376;aulast=